Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Feb 28, 2025 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.96%7.32B | 12.64%1.78B | 17.01%1.62B | 39.48%6.54B | 22.56%1.78B | 29.81%1.79B | 72.17%1.58B | 48.03%1.38B | 74.67%4.69B | 85.86%1.46B |
| Cost of revenue | 9.98%4.44B | 6.47%1.07B | 20.08%1.05B | 46.88%4.04B | 21.43%1.07B | 25.43%1.08B | 98.87%1.01B | 76.18%875.61M | 111.44%2.75B | 147.58%878.86M |
| Gross profit | 15.16%2.88B | 23.53%705.26M | 11.70%564.76M | 28.98%2.5B | 24.27%716.61M | 37.15%706.55M | 39.18%570.94M | 15.95%505.59M | 40.12%1.94B | 34.69%576.64M |
| Operating expense | 20.19%2.79B | 19.48%669.61M | 24.26%662.24M | 33.54%2.32B | 35.79%636.83M | 32.58%587.36M | 46.59%560.46M | 20.80%532.96M | 33.21%1.74B | 51.20%468.99M |
| Operating profit | -48.74%93.33M | 240.23%35.65M | -256.16%-97.49M | -10.10%182.08M | -25.89%79.77M | 65.19%119.2M | -62.43%10.48M | -430.88%-27.37M | 152.01%202.53M | -8.73%107.65M |
| Net non-operating interest income (expenses) | -13.58%-36.07M | 29.32%-8.79M | -61.32%-7.37M | -57.10%-31.75M | 22.74%-8.76M | -93.07%-5.99M | -354.03%-12.44M | -50.74%-4.57M | -352.68%-20.21M | -1,209.82%-11.34M |
| Non-operating interest income | 716.67%1.42M | 344.90%218K | 35.90%53K | 0.00%174K | -2.08%47K | 0.00%39K | 2.08%49K | 0.00%39K | 180.65%174K | 700.00%48K |
| Non-operating interest expense | 21.25%32.36M | -15.37%6.13M | 61.11%7.42M | 72.20%26.69M | 35.47%8.81M | 91.91%6.03M | 160.03%7.25M | 50.10%4.61M | 242.37%15.5M | 645.87%6.5M |
| Total other finance cost | -2.16%5.13M | ---- | ---- | 7.18%5.24M | --0 | --0 | ---- | ---- | --4.89M | ---- |
| Net investment income | 1,278.95%1.05M | 472K | 368K | 24.59%76K | 0.00%10K | 40.00%35K | -74.15%61K | -90.38%10K | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 130.52%18.51M | -1,447.62%-19.53M | 1,403.57%27.77M | -491.33%-60.65M | -251.71%-30.06M | -3,144.53%-31.18M | 89.76%-1.26M | -73.56%1.85M | -77.89%15.5M | 130.94%19.82M |
| Income from associates and other participating interests | -98.41%41K | 0 | -133.58%-640K | 589.04%2.58M | 0 | 2.85M | 0 | -274K | 374K | 374K |
| Special income (charges) | -36,510.13%-762.59M | 0 | 0 | 87.56%-2.08M | 0 | 0 | 0 | 85.30%-2.08M | -456.16%-16.74M | -398.49%-2.58M |
| Less:Other special charges | -145.70%-952K | ---- | ---- | -87.56%2.08M | --0 | --0 | --0 | -85.30%2.08M | 456.16%16.74M | 398.49%2.58M |
| Less:Write off | --763.54M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 7.90%-6.85M | 94.60%-800K | -12.10%516K | 84.89%-7.44M | -16.97%5.45M | 104.80%1.35M | -367.63%-14.82M | 102.40%587K | -42,873.91%-49.19M | 329.58%6.57M |
| Income before tax | -936.40%-692.57M | 138.87%7M | -141.15%-76.84M | -37.42%82.8M | -61.48%46.41M | 105.63%86.27M | -286.18%-18.01M | 19.95%-31.86M | -12.39%132.32M | 135.67%120.5M |
| Income tax | 196.78%168.87M | 189.43%32.38M | 42.67%-7.73M | -293.78%-174.5M | -362.22%-201.08M | 222.91%76.28M | -576.90%-36.21M | 24.43%-13.49M | 287.59%90.05M | 420.71%76.68M |
| Net income | -434.80%-861.45M | -239.50%-25.38M | -276.11%-69.1M | 508.67%257.3M | 464.92%247.49M | -45.50%9.99M | 773.82%18.19M | 16.30%-18.37M | -66.93%42.27M | -41.62%43.81M |
| Net income continuous operations | -434.80%-861.45M | -239.49%-25.38M | -276.11%-69.1M | 508.65%257.3M | 464.89%247.49M | -45.50%9.99M | 773.40%18.19M | 16.30%-18.37M | -66.92%42.27M | -41.62%43.81M |
| Noncontrolling interests | -1.07M | 0 | 0 | 0 | -370K | 0 | ||||
| Net income attributable to the company | -434.38%-860.38M | -241.60%-25.76M | -276.11%-69.1M | 503.37%257.3M | 464.91%247.49M | -45.50%9.99M | 774.24%18.19M | 14.86%-18.37M | -66.64%42.64M | -41.62%43.81M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -434.38%-860.38M | -241.60%-25.76M | -276.11%-69.1M | 503.37%257.3M | 464.91%247.49M | -45.50%9.99M | 774.24%18.19M | 14.86%-18.37M | -66.64%42.64M | -41.62%43.81M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -434.37%-142.61 | -241.86%-4.27 | -276.64%-11.45 | 485.85%42.65 | 448.40%41.02 | -48.61%1.66 | 401.67%3.01 | 24.57%-3.04 | -70.24%7.28 | -47.91%7.48 |
| Diluted earnings per share | -434.69%-142.61 | -241.90%-4.27 | -276.64%-11.45 | 486.11%42.61 | 463.77%40.99 | -45.34%1.656 | 774.96%3.0092 | 24.57%-3.04 | -70.18%7.27 | -49.19%7.2706 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |